IL-1β induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons

被引:59
作者
Davis, Christopher N. [1 ]
Tabarean, Iustin [1 ]
Gaidarova, Svetlana [1 ]
Behrens, M. Margarita [1 ]
Bartfai, Tamas [1 ]
机构
[1] Scripps Res Inst, Harold L Dorris Neurol Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA
关键词
cytokine; hypothalamus; inflammation; interleukin; neuron; tyrosine kinase;
D O I
10.1111/j.1471-4159.2006.03951.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proinflammatory cytokine interleukin1 beta (IL-1 beta), acting at IL-1R1 receptors, affects neuronal signaling under both physiological and pathophysiological conditions. The molecular mechanism of the rapid synaptic actions of IL-1 beta in neurons is not known. We show here that within minutes of IL-1 beta exposure, the firing rate of anterior hypothalamic (AH) neurons in culture was inhibited. This effect was prevented by pre-exposure of the cells to the Src family inhibitor, PP2, suggesting the involvement of Src in the hyperpolarizing effects of IL-1 beta. The IL-1 beta stimulation of neurons induced a rapid increase in the phosphorylation of the tyrosine kinase Src and kinase suppressor of Ras (ceramide activated protein kinase (CAPK)/KSR) in neurons grown on glia from IL-1RI(-/-) mice. These effects of IL-1 beta were dependent on the association of the cytosolic adaptor protein, MyD88, to the IL-1 receptor, and on the activation of the neutral sphingomyelinase, leading to production of ceramide. A cell-permeable analog of ceramide mimicked the effects of IL-1 beta on the cultured AH neurons. These results suggest that ceramide may be the second messenger of the fast IL-1 beta actions in AH neurons, and that this IL-1 beta/ceramide pathway may underlie the fast non-transcription-dependent, electrophysiological effects of IL-1 beta observed in AH neurons in vivo.
引用
收藏
页码:1379 / 1389
页数:11
相关论文
共 70 条
[1]   FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase [J].
AdamKlages, S ;
Adam, D ;
Wiegmann, K ;
Struve, S ;
Kolanus, W ;
SchneiderMergener, J ;
Kronke, M .
CELL, 1996, 86 (06) :937-947
[2]   Interleukin-1 and neuronal injury [J].
Allan, SM ;
Tyrrell, PJ ;
Rothwell, NJ .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (08) :629-640
[3]  
Arenz C, 2000, ANGEW CHEM INT EDIT, V39, P1440, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1440::AID-ANIE1440>3.0.CO
[4]  
2-R
[5]   A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses [J].
Bartfai, T ;
Behrens, MM ;
Gaidarova, S ;
Pemberton, J ;
Shivanyuk, A ;
Rebek, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7971-7976
[6]   INTERLEUKIN-1-BETA INHIBITS SYNAPTIC STRENGTH AND LONG-TERM POTENTIATION IN THE RAT CA1 HIPPOCAMPUS [J].
BELLINGER, FP ;
MADAMBA, S ;
SIGGINS, GR .
BRAIN RESEARCH, 1993, 628 (1-2) :227-234
[7]   Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis [J].
Birbes, H ;
El Bawab, S ;
Hannun, YA ;
Obeid, LM .
FASEB JOURNAL, 2001, 15 (14) :2669-2679
[8]   De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase [J].
Blázquez, C ;
Galve-Roperh, I ;
Guzmán, M .
FASEB JOURNAL, 2000, 14 (14) :2315-2322
[9]   Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms [J].
Bock, J ;
Szabó, I ;
Gamper, N ;
Adams, C ;
Gulbins, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (04) :890-897
[10]   Ceramide-enriched membrane domains [J].
Bollinger, CR ;
Teichgräber, V ;
Gulbins, E .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2005, 1746 (03) :284-294